Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Tronics’ 2008 Sales Totaled 11 Million Euros ($16.3 Million); Net Profit Was 858,000 Euros ($1.3 Million)

Abstract:
Leading MEMS Manufacturer Achieves 10 Consecutive Profitable Quarters, While Absorbing Both Acquisition Costs and Global Economic Downturn

Tronics’ 2008 Sales Totaled 11 Million Euros ($16.3 Million); Net Profit Was 858,000 Euros ($1.3 Million)

CROLLES, France, DALLAS, TX , and SUNNYVALE, CA | Posted on April 15th, 2009

Tronics, a leading global integrated manufacturer of custom MEMS, today announced that 2008 revenue totaled 11 million Euros ($16.3 million), representing a 5 percent increase (13 percent USD) compared to 2007. Net profit for 2008 totaled 8 percent of revenue or 858,000 Euros ($1.3M).

Tronics was profitable and achieved growth and generated cash while absorbing the cost of its U.S. expansion in the fourth-quarter. The company ended 2008 with its 10th consecutive profitable quarter. These achievements were realized against a steadily declining global economic environment in the fall. With a strong balance sheet that includes more than 5 million Euros cash and a debt/equity ratio below 30 percent, Tronics is well positioned to manage its business in 2009 and continue its expansion in 2010 and beyond.

Tronics extended its global reach and industry scope by creating a U.S. operation in Dallas and acquiring a full-service medical device design-and-development group based in Sunnyvale. These two strategic events are aligned with Tronics' goals of penetrating the medical device sector and meeting the growing demand for custom MEMS components manufacturing in the United States, Europe and Asia.

"Tronics' business fundamentals and operations are on secure footing. Even though we are facing a reduced demand from markets like oil exploration and aerospace in 2009, we are in a far better position than many companies in our field," said Peter Pfluger, CEO of Tronics. "Furthermore, our U.S. entities are already well integrated and operational. We are realizing the first synergistic benefits of our new operations in our U.S. and medical businesses."

Tronics' MEMS manufacturing operations in Crolles and Dallas have an annual capacity of more than 60,000 wafers in addition to assembly and packaging capabilities.

####

About Tronics
Tronics is a global leading integrated manufacturer of custom MEMS. With operations in the U.S. and Europe and representation in Asia, Tronics provides local support to customers and offers one of the broadest technology portfolios in the industry. The company transforms MEMS concepts into products and builds reliable supply chains for integrated components. Tronics services range from R&D prototyping to high-volume MEMS manufacturing, including electronic interface development, assembly and custom packaging, with additional capabilities in medical device development.

For more information, please click here

Contacts:
Company Contact
Vincent Gaff
Tronics’ Public Relations Manager
+33 4 76 97 29


Sarah-Lyle Dampoux
Account Supervisor
Loomis Group
+33 1 58 18 59 30


paola tarazona
account coordinator

loomis::group
www.loomisgroup.com
phone + 33 (0)1 58 18 59 30 ext 105
paris san francisco beijing boston
hong kong shanghai shenzhen tokyo

Copyright © Tronics

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Researchers develop artificial building blocks of life March 8th, 2024

How surface roughness influences the adhesion of soft materials: Research team discovers universal mechanism that leads to adhesion hysteresis in soft materials March 8th, 2024

Two-dimensional bimetallic selenium-containing metal-organic frameworks and their calcinated derivatives as electrocatalysts for overall water splitting March 8th, 2024

Curcumin nanoemulsion is tested for treatment of intestinal inflammation: A formulation developed by Brazilian researchers proved effective in tests involving mice March 8th, 2024

MEMS

Bosch launches longevity program for industrial and IoT applications: High-performance accelerometer, IMU and pressure sensor with 10-year availability July 23rd, 2020

CEA-Leti Develops Tiny Photoacoustic-Spectroscopy System For Detecting Chemicals & Gases: Paper at Photonics West to Present Detector that Could Cost 10x Less Than Existing Systems and Prompt Widespread Use of the Technology February 4th, 2020

MEMS & Sensors Executive Congress Technology Showcase Finalists Highlight Innovations in Automotive, Biomedical and Consumer Electronics: MSIG MEMS & Sensors Executive Congress – October 22-24, 2019, Coronado, Calif. October 1st, 2019

ULVAC Launches Revolutionary PZT Piezoelectric Thin-film Process Technology and HVM Solution for MEMS Sensors/Actuators: Enabling Reliable, High-quality Film Production for Next Generation Devices August 16th, 2019

Announcements

What heat can tell us about battery chemistry: using the Peltier effect to study lithium-ion cells March 8th, 2024

Curcumin nanoemulsion is tested for treatment of intestinal inflammation: A formulation developed by Brazilian researchers proved effective in tests involving mice March 8th, 2024

The Access to Advanced Health Institute receives up to $12.7 million to develop novel nanoalum adjuvant formulation for better protection against tuberculosis and pandemic influenza March 8th, 2024

Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024

Financial Reports

180 Degree Capital Corp. Reports +14.2% Growth in Q1 2021, $10.60 Net Asset Value Per Share as of March 31, 2021, and Developments From Q2 2021 May 11th, 2021

Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021

Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021

180 Degree Capital Corp. Reports +6.7% Growth in Q4 2020, $9.28 Net Asset Value per Share as of December 31, 2020, and Developments from Q1 2021 Including Expected Investment in a Planned SPAC Sponsor February 22nd, 2021

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project